Saturday 17 October 2026 Export HITI’s income statement to Excel — free account

High Tide Inc.

HITI Healthcare Pharmaceutical Retailers

High Tide Inc.’s revenue for fiscal 2025 (year ended October 2025) was $424.0 million, up 10.5% from fiscal 2024. In the quarter to July 2026, revenue grew 30.7%, EPS grew 800.0%, free cash flow fell 7.91% and total debt rose 54.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

2.57 0.01 +0.39%

Follow HITI

Alert me

Market cap: $228.2M
P/E: 0.0×
Fwd P/E: 92.0×
Dividend yield: —
F-score: 2/9
Altman Z: 1.52
Beneish M: −3.01
Dividend safety: 25/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 11.39%

Capital & Financial Ratios $m

Market Cap 228.20

Revenue 519.66

Net Income (24.39)

Free Cash Flow 11.14

Net Debt 45.73

Current Ratio 1.50

Debt/Equity 0.93

P/E ratio 0.00

Fwd P/E 92.00

P/S ratio 0.43

P/B ratio 2.63

Past 5Y EPS Growth —

This Y EPS Growth 127.19%

Next Y EPS Growth 10.36%

Next Y revenue growth 24.90%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 36.32%

10-year low 10-year high

P/B against its own 10 years 60.43%

10-year low 10-year high

EV/Sales against its own 10 years 42.28%

10-year low 10-year high

EV/FCF against its own 10 years 79.15%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	22	35	34	34
Receivables	6	2	4	7
Inventory	19	22	48	48
Other	—	—	—	—
	51	63	98	105

	2023	2024	2025	Q'26
Payables	15	17	34	38
ST’ Debt	18	9	12	10
Other	3	—	7	3
	43	45	71	70

Compound Annual Growth %

	10y	5y	3y
Sales	—	46.92%	15.22%
Cash Flow	—	20.95%	69.61%
Earnings	—	0.00%	0.00%
Book Value	—	53.11%	(16.46%)

Revenue $m

	Jan	Apr	Jul	Oct	Year
’26	129	131	142	—	—
’25	100	97	109	118	424
’24	95	92	96	101	384
’23	88	89	93	92	362
’22	57	64	74	82	277
’21	30	32	39	43	144
’20	10	14	17	20	62

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Jan	Apr	Jul	Oct	Year
’26	4	3	7	—	—
’25	0	6	8	3	17
’24	5	9	4	7	26
’23	2	1	6	7	15
’22	(1)	(2)	0	6	3
’21	1	(3)	(4)	4	(2)
’20	0	2	4	1	7

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Jan	Apr	Jul	Oct	Year
’26	3	2	6	—	—
’25	(1)	4	6	1	10
’24	4	8	2	6	20
’23	0	0	5	5	11
’22	(3)	(4)	(2)	6	(4)
’21	0	(5)	(4)	1	(9)
’20	0	2	3	1	5

Fiscal quarters ending in the months shown.

EPS $

	Jan	Apr	Jul	Oct	Year
’26	0.01	0.00	0.09	—	—
’25	(0.02)	(0.03)	0.01	(0.33)	(0.44)
’24	0.00	0.00	0.01	(0.04)	(0.04)
’23	(0.04)	(0.02)	(0.03)	(0.29)	(0.39)
’22	(0.11)	(0.11)	(0.03)	(0.64)	(0.89)
’21	(0.02)	(0.02)	(0.03)	(0.07)	(0.67)
’20	(0.02)	(0.02)	0.01	(0.11)	(0.02)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	1.80	0.65	2.78	1.30	1.03	1.57	1.64	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	7.10	3.30	13.29	5.89	2.30	3.62	4.06
People
People	Employees	—	—	—	—	—	996	1,300	1,550	1,550	1,832
	Revenue/emp, $m	—	0.00	0.00	0.00	0.00	0.14	0.21	0.23	0.25	0.23
Income, $m
Income, $m	Revenue	—	8	7	24	62	144	277	362	384	424
	Gross margin, %	—	46.83	0.98	36.16	37.00	35.33	28.29	26.93	27.28	25.85
	EBT	—	0	(5)	(20)	(5)	(28)	(57)	(36)	(3)	(37)
	EBT margin, %	—	5.62	(68.90)	(86.28)	(7.36)	(19.75)	(20.67)	(9.96)	(0.84)	(8.66)
	Net income	—	0	(3)	(20)	(5)	(28)	(55)	(30)	(3)	(37)
	Depreciation	—	0	0	1	5	19	23	24	19	17
Per share, $
Per share, $	Revenue	—	0.62	0.53	0.12	0.27	3.39	4.42	4.86	4.82	5.16
	Earnings	—	0.02	(0.27)	(0.10)	(0.02)	(0.67)	(0.89)	(0.39)	(0.04)	(0.44)
	Cash flow	—	0.06	(0.53)	(0.06)	0.03	(0.05)	0.06	0.21	0.33	0.21
	Capex	—	0.00	0.00	(0.04)	(0.01)	(0.15)	(0.11)	(0.06)	(0.08)	(0.09)
	Free cash flow	—	0.06	(0.53)	(0.10)	0.02	(0.21)	(0.06)	0.15	0.25	0.12
	Book value	—	(0.60)	1.42	0.04	0.04	2.85	2.01	1.33	1.34	0.89
	Shares, m	—	13	13	198	229	42	63	74	80	82
Valuation, ×
Valuation, ×	P/E	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	0.00	0.00	0.00	0.51	1.70	0.33	0.30	0.58	0.60
	P/B	—	79.07	79.07	79.07	4.08	2.03	0.73	1.09	2.10	3.48
	EV/Sales	—	0.00	0.00	0.00	0.99	1.86	0.43	0.37	0.59	0.69
	EV/FCF	—	0.00	0.00	0.00	8.58	(30.46)	(33.98)	12.37	11.61	30.10
Cash, $m
Cash, $m	Operating cash flow	—	1	(7)	(11)	7	(2)	3	15	26	17
	Capex	—	0	(3)	(8)	(2)	(7)	(7)	(5)	(7)	(7)
	Free cash flow	—	1	(7)	(19)	5	(9)	(4)	11	20	10
Balance, $m
Balance, $m	Working capital	—	(8)	11	1	(6)	4	3	8	18	26
	Total debt	—	14	0	15	32	35	48	48	38	70
	Net debt	—	13	(6)	15	26	23	29	26	3	36
	Shareholders’ equity	—	(7)	18	7	9	121	126	99	107	73
Returns, %
Returns, %	ROA	—	1.62	(34.87)	(78.43)	(11.45)	(22.49)	(27.24)	(15.08)	(1.80)	(16.85)
	ROIC	—	0.00	0.00	(42.85)	1.06	(5.50)	(22.71)	(15.36)	2.09	(5.89)
	ROE	—	4.45	(66.85)	(158.98)	(59.84)	(43.00)	(45.18)	(25.91)	(3.09)	(40.19)

Negative figures in brackets.

All 10 years →

Fiscal years to Oct 2025 · latest quarter Jul 2026 · fundamentals updated 2 Oct 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
HITI High Tide Inc.	$228.2M	— (loss-making)	92.0×	+30.72% (above 0%: growing)	+800.00% (above 0%: growing)	−7.91% (below 0%: shrinking)	26.53%	4.38%
PETS PetMed Express, Inc.	$26.4M	— (loss-making)	24.0×	−19.86% (below 0%: shrinking)	n/m	+38.60% (above 0%: growing)	27.63%	(15.19%)	Compare
MEDS DataMeds AI, Inc	$12.8M	— (loss-making)	—	−77.15% (below 0%: shrinking)	n/m	−41.85% (below 0%: shrinking)	10.24%	(412.67%)	Compare
SCNX Scienture Holdings, Inc.	$5.6M	— (loss-making)	— (loss-making)	+3,235.92% (above 0%: growing)	n/m	−53.98% (below 0%: shrinking)	97.73%	(785.71%)	Compare
POM Pomdoctor Limited - Sponsored ADR	$5.0M	—	—	—	—	—	—	—	Compare
RDGT Ridgetech Inc.	$3.0M	— (loss-making)	— (loss-making)	+113.14% (above 0%: growing)	n/m	+4,848.31% (above 0%: growing)	22.81%	0.00%	Compare
MDVLQ MedAvail Holdings, Inc.	$2.9M	— (loss-making)	— (loss-making)	−25.41% (below 0%: shrinking)	n/m	+66.32% (above 0%: growing)	43.95%	(1,099.75%)	Compare
BIMI BIMI Holdings Inc.	$170.0K	— (loss-making)	—	−48.85% (below 0%: shrinking)	n/m	+28.06% (above 0%: growing)	4.57%	(124.83%)	Compare
Median of peers	$5.0M	—	—	−22.63%	—	+33.33%	25.22%	(268.75%)

All 8 Pharmaceutical Retailers stocks →

High Tide Inc. (HITI) key facts

Strength: High Tide Inc.’s revenue for fiscal 2025 (year ended October 2025) was $424.0 million, up 10.5% from fiscal 2024.
High Tide Inc. (HITI) is a Pharmaceutical Retailers company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, HITI traded at $2.57, a market capitalization of $228.2 million.
Return on equity was −40.2% and debt-to-equity 0.93.
Its Piotroski F-score is 2 out of 9 and its Altman Z-score is 1.52 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations · fundamentals updated Oct 2, 2026.